How Gula The Sumerian Goddess Offered The Most Famous Painkiller to Humanity?
Ari Massoudi
I do stuff enabling Mankind to live longer, stronger and smarter ?????????=>??
The Epic Tale of Aspirin: A Journey Through Time and Serendipity
Aspirin, a household name and medical marvel, has a rich history spanning millennia. From ancient willow bark remedies to modern-day wonder drug, its journey is a testament to human ingenuity, scientific progress, and serendipitous discoveries.
Ancient Roots
The story of aspirin begins in antiquity. As early as 5000-1750 BC, the Sumerians were using willow leaf decoctions for pain relief. This practice was not limited to Mesopotamia; an Egyptian papyrus from 1550 BC also mentions willow leaf remedies. Even Hippocrates, the father of medicine, prescribed willow bark for fever and pain in ancient Greece.
From Folklore to Science
The transition from folk remedy to scientific inquiry began in earnest in the 18th century. On June 2, 1763, Edward Stone, an Anglican pastor, presented a groundbreaking paper to the Royal Society of London, confirming the fever-reducing properties of willow leaf infusions.
The 19th century saw rapid advancements:
1825: An Italian pharmacist isolates salicin, the active ingredient in willow bark.
1829: Henri Leroux, a French pharmacist, refines the extraction process.
1835: Karl J. L?wig extracts salicin from meadowsweet.
1839: Raffaele Piria obtains salicylic acid through hydrolysis of salicin.
The Birth of Aspirin
The pivotal moment came in 1898 when Felix Hoffman, a chemist at Bayer, rediscovered and refined acetylsalicylic acid. Hoffman's work was motivated by a personal quest to find a remedy for his father's rheumatism. In 1899, Bayer marketed this compound under the name "Aspirin," a clever blend of "a" for acetyl, "spir" for Spiraea ulmaria (meadowsweet), and "in" as a fashionable medical suffix.
Serendipity in Action
Aspirin's journey is peppered with serendipitous discoveries. When Bayer distributed aspirin to doctors and dentists, one dentist, lacking antipyrine, administered aspirin to a patient with dental pain. The patient's quick relief led to aspirin being recommended for neuralgia.
In the late 1940s, Dr. Lawrence Craven made a crucial observation. He noticed that patients chewing aspirin gum after tonsil surgery tended to bleed more, leading to the discovery of aspirin's anticoagulant properties.?
Modern Understanding and Applications
Today, aspirin is recognized as a nonsteroidal anti-inflammatory drug (NSAID) that works by irreversibly inhibiting COX-1 (cyclooxygenase-1). This mechanism confers protection against platelet-mediated thrombotic events while increasing bleeding risk, setting up its clinical risk-benefit tradeoff.
Aspirin's uses have expanded far beyond its original pain-relieving properties:
The Controversy of Discovery
The question of who truly discovered aspirin remains contentious. While Felix Hoffman is often credited, some argue that Arthur Eichengrün, another Bayer chemist, was the true discoverer. This controversy highlights the complex nature of scientific discovery and the importance of recognizing all contributors.
Aspirin in the Modern Era
Over a century after its introduction, aspirin remains one of the most widely consumed drugs globally. Its annual production reaches around 40,000 tonnes, with a turnover of one billion dollars4. However, its use is not without risks. Recent guidelines have become more cautious about recommending aspirin for primary prevention of cardiovascular disease, especially in older adults, due to increased bleeding risks.
The Future: AI and Drug Discovery
While serendipity played a significant role in aspirin's history, the future of drug discovery lies in more systematic approaches. Artificial Intelligence (AI) is revolutionizing pharmaceutical research, offering the potential to analyze vast datasets, identify patterns, and predict outcomes with unprecedented accuracy.
AI could accelerate the discovery of new drugs, potentially uncovering compounds with aspirin-like versatility but improved safety profiles. It could also help in personalizing medicine, determining which patients are most likely to benefit from aspirin therapy while minimizing risks.
If you're interested by AI-driven drug discovery ??????
ITW Dr. Ivan De Weber, PhD - Cofounder-CEO at Cortex Discovery
Exciting news! ?? Join us for the next episode of our LinkedIn Live podcast featuring Dr. Ivan De Weber, PhD, co-founder and CEO of Cortex Discovery, a groundbreaking startup revolutionizing drug discovery through AI!
?? From Academia to AI-Powered Drug Discovery
Dr. de Weber's journey is nothing short of inspiring. We'll explore his transition from cellular biology and pharmaceutical bioinformatics to founding a company at the cutting edge of AI-driven drug discovery. Learn how his lifelong quest for longevity research led to the creation of Cortex Discovery.
?? Unveiling Cortex Discovery's Innovative Approach
Discover how Cortex Discovery is disrupting preclinical drug discovery across all therapeutic areas with their proprietary AI models. We'll delve into:
? Their foundation model for drug property predictions
? The vast database of 750 million data points powering their deep learning system
? Recent breakthroughs, including the first AI-discovered compound proven to extend lifespan in a whole organism
?? Business Insights and Future Outlook
Get an insider's perspective on:
? Cortex Discovery's unique business model and collaboration opportunities
? Challenges faced in the AI-driven drug discovery landscape
? The company's vision for the future of longevity research and pharmaceutical development
This episode is a must-watch for:
? Biotech and pharmaceutical executives
? Investors in the life sciences sector
? Academic researchers in pharmaceutical chemistry, longevity biology, and clinical medicine
? Anyone interested in the intersection of AI and drug discovery
Don't miss this opportunity to gain valuable insights into the future of AI-powered drug discovery and longevity research. Tune in to our LinkedIn Live podcast and be part of the conversation shaping the future of medicine!